Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2016 by University of Tennessee
Sponsor:
Collaborators:
Icahn School of Medicine at Mount Sinai
Ann & Robert H Lurie Children's Hospital of Chicago
University of Colorado, Denver
University of California, San Francisco
University of Pittsburgh
Phoenix Children's Hospital
Children's Hospital of Philadelphia
Children's Healthcare of Atlanta
Children's Hospital Los Angeles
Texas Children's Hospital
Yale University
Information provided by (Responsible Party):
University of Tennessee
ClinicalTrials.gov Identifier:
NCT01088607
First received: March 12, 2010
Last updated: July 20, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)